(Q40857012)

English

Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness

scientific article published on 9 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Gabriella Fontanini

9

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Agnese Proietti

object named as

Agnese Proietti

6

0 references

Riccardo Giannini

object named as

Riccardo Giannini

3

0 references

object named as

Fulvio Basolo

8

0 references

author name string

Elisabetta Macerola

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Barbara Loggini

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Giulia Garavello

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Mirella Giordano

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Cristina Niccoli

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

9 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

467

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

177-184

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Targeted therapy for melanoma: a primer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Molecular biology of melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

TERT promoter mutations in familial and sporadic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Highly recurrent TERT promoter mutations in human melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Regulation of the human catalytic subunit of telomerase (hTERT).

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Frequency of TERT promoter mutations in human cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

TERT promoter mutation is uncommon in acral lentiginous melanoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

Integration of MAP kinase signal transduction pathways at the serum response element

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1784-X

21 January 2018

elk-1 proteins interact with MAP kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26055532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26055532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic and prognostic biomarkers in melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26055532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF mutations in metastatic melanoma: a possible association with clinical outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26055532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006

1 reference

https://pubmed.ncbi.nlm.nih.gov/26055532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26055532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-015-1784-X

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40857012&oldid=2204040303"